Insider Trading - Prometheus Biosciences Inc. (RXDX)
Real time insider trading transaction history:
- Insiders must file a Form 4 covering their trades within two business days.
- Section 16 prohibits insiders from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-03-16 Purchase | 2021-03-16 7:57 pm | Prometheus Biosciences Inc. | RXDX | RTW INVESTMENTS LP WONG RODERICK 10% Owner | 800,000 | $19 | $15,200,000 | 3,264,031 (Indirect) | View |
| 2021-03-16 Purchase | 2021-03-16 8:30 pm | Prometheus Biosciences Inc. | RXDX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner | 850,000 | $19 | $16,150,000 | 3,314,032 (Indirect) | View |
| 2021-03-16 Purchase | 2021-03-16 9:47 pm | Prometheus Biosciences Inc. | RXDX | Adams Helen C. Director | 500 | $19 | $9,500 | 500 (Direct) | View |
| 2021-03-16 Purchase | 2021-03-16 9:48 pm | Prometheus Biosciences Inc. | RXDX | PAPA JOSEPH C Director | 15,000 | $19 | $285,000 | 15,000 (Direct) | View |
| 2021-03-16 Purchase | 2021-03-16 9:49 pm | Prometheus Biosciences Inc. | RXDX | Stenhouse Mark COO | 14,000 | $19 | $266,000 | 14,000 (Direct) | View |
| 2021-03-16 Purchase | 2021-03-17 7:47 pm | Prometheus Biosciences Inc. | RXDX | Point72 Biotech Private Investments LLC Differentiated Ventures Investments LLC 72 Investment Holdings LLC COHEN STEVEN A/SAC CAPITAL MGMT LP Former 10% Owner | 800,000 | $19 | $15,200,000 | 2,648,024 (Indirect) | View |
| 2021-03-16 Purchase | 2021-03-18 4:43 pm | Prometheus Biosciences Inc. | RXDX | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund III LP Former 10% Owner | 375,000 | $19 | $7,125,000 | 2,223,022 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-03-11 Option Award | 2021-03-11 9:47 pm | N/A 2031-03-10 | Prometheus Biosciences Inc. | RXDX | Szela Mary T Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2021-03-16 Conversion | 2021-03-16 7:57 pm | N/A N/A | Prometheus Biosciences Inc. | RXDX | RTW INVESTMENTS LP WONG RODERICK 10% Owner | 27,104,357 | $0 | 3,264,031 (Indirect) | View |
| 2021-03-16 Conversion | 2021-03-16 8:30 pm | N/A N/A | Prometheus Biosciences Inc. | RXDX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner | 27,104,358 | $0 | 3,314,032 (Indirect) | View |
| 2021-03-16 Conversion | 2021-03-16 9:51 pm | N/A N/A | Prometheus Biosciences Inc. | RXDX | Yamada Tadataka Chairman | 146,667 | $0 | 13,333 (Direct) | View |
| 2021-03-16 Conversion | 2021-03-16 9:53 pm | N/A N/A | Prometheus Biosciences Inc. | RXDX | CEDARS SINAI MEDICAL CENTER 10% Owner | 48,576,089 | $0 | 5,008,508 (Direct) | View |
| 2021-03-16 Conversion | 2021-03-17 7:47 pm | N/A N/A | Prometheus Biosciences Inc. | RXDX | Point72 Biotech Private Investments LLC Differentiated Ventures Investments LLC 72 Investment Holdings LLC COHEN STEVEN A/SAC CAPITAL MGMT LP Former 10% Owner | 20,328,269 | $0 | 2,648,024 (Indirect) | View |
| 2021-03-16 Conversion | 2021-03-18 4:43 pm | N/A N/A | Prometheus Biosciences Inc. | RXDX | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund III LP Former 10% Owner | 3,696,045 | $0 | 2,223,022 (Indirect) | View |
| 2021-04-14 Option Award | 2021-04-16 6:40 pm | N/A 2031-04-13 | Prometheus Biosciences Inc. | RXDX | Hendrix Martin Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2021-04-14 Option Award | 2021-04-16 6:46 pm | N/A 2031-04-13 | Prometheus Biosciences Inc. | RXDX | Laur James Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2021-05-14 Option Award | 2021-05-17 7:24 pm | N/A 2031-05-13 | Prometheus Biosciences Inc. | RXDX | Hassan Fred Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2021-09-08 Option Award | 2021-09-15 8:09 pm | N/A 2031-09-07 | Prometheus Biosciences Inc. | RXDX | Luo Allison Chief Medical Officer | 4,500 | $0 | 4,500 (Indirect) | View |
| 2021-11-14 Option Award | 2021-11-16 9:03 pm | N/A 2031-11-13 | Prometheus Biosciences Inc. | RXDX | McKenna Mark C. CEO Chairman | 290,000 | $0 | 290,000 (Direct) | View |
| 2021-11-14 Option Award | 2021-11-16 9:06 pm | N/A 2031-11-13 | Prometheus Biosciences Inc. | RXDX | Luo Allison Chief Medical Officer | 113,677 | $0 | 113,677 (Direct) | View |
| 2021-11-14 Option Award | 2021-11-16 9:08 pm | N/A 2031-11-13 | Prometheus Biosciences Inc. | RXDX | Marshall Keith W CFO | 102,155 | $0 | 102,155 (Direct) | View |
| 2021-11-14 Option Award | 2021-11-16 9:10 pm | N/A 2031-11-13 | Prometheus Biosciences Inc. | RXDX | Stenhouse Mark COO | 70,371 | $0 | 70,371 (Direct) | View |
| 2021-11-14 Option Award | 2021-11-16 9:12 pm | N/A 2031-11-13 | Prometheus Biosciences Inc. | RXDX | Andrews Timothy K. General Counsel | 54,132 | $0 | 54,132 (Direct) | View |
| 2021-11-14 Option Award | 2021-11-16 9:15 pm | N/A 2031-11-13 | Prometheus Biosciences Inc. | RXDX | PAPA JOSEPH C Director | 2,165 | $0 | 2,165 (Direct) | View |
| 2021-11-14 Option Award | 2021-11-16 9:17 pm | N/A 2031-11-13 | Prometheus Biosciences Inc. | RXDX | Adams Helen C. Director | 1,083 | $0 | 1,083 (Direct) | View |
| 2021-11-14 Option Award | 2021-11-16 9:19 pm | N/A 2031-11-13 | Prometheus Biosciences Inc. | RXDX | Hassan Fred Director | 541 | $0 | 541 (Direct) | View |